
Michelle M. Iacoletti
Examiner (ID: 9693, Phone: (571)270-5789 , Office: P/2882 )
| Most Active Art Unit | 2882 |
| Art Unit(s) | 2882, 4185, 4100, 2877 |
| Total Applications | 628 |
| Issued Applications | 540 |
| Pending Applications | 11 |
| Abandoned Applications | 82 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14793857
[patent_doc_number] => 10399920
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-03
[patent_title] => Crystalline form of cannabidiol
[patent_app_type] => utility
[patent_app_number] => 15/609228
[patent_app_country] => US
[patent_app_date] => 2017-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 15
[patent_no_of_words] => 9824
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15609228
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/609228 | Crystalline form of cannabidiol | May 30, 2017 | Issued |
Array
(
[id] => 16358480
[patent_doc_number] => 20200315231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => CO-CRYSTALLINE SUCROSE
[patent_app_type] => utility
[patent_app_number] => 16/305307
[patent_app_country] => US
[patent_app_date] => 2017-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4690
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16305307
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/305307 | CO-CRYSTALLINE SUCROSE | May 29, 2017 | Abandoned |
Array
(
[id] => 14639063
[patent_doc_number] => 10364264
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-30
[patent_title] => Proliferative disease treatment methods with phosphaplatin complexes
[patent_app_type] => utility
[patent_app_number] => 15/604237
[patent_app_country] => US
[patent_app_date] => 2017-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11746
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15604237
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/604237 | Proliferative disease treatment methods with phosphaplatin complexes | May 23, 2017 | Issued |
Array
(
[id] => 14731387
[patent_doc_number] => 10385083
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-20
[patent_title] => Phosphaplatin complexes and methods for treatment of proliferative diseases using the phosphaplatin complexes
[patent_app_type] => utility
[patent_app_number] => 15/604209
[patent_app_country] => US
[patent_app_date] => 2017-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11743
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15604209
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/604209 | Phosphaplatin complexes and methods for treatment of proliferative diseases using the phosphaplatin complexes | May 23, 2017 | Issued |
Array
(
[id] => 16389551
[patent_doc_number] => 20200330492
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => SYNTHETIC COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/303131
[patent_app_country] => US
[patent_app_date] => 2017-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7559
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16303131
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/303131 | Synthetic composition | May 18, 2017 | Issued |
Array
(
[id] => 15054705
[patent_doc_number] => 10457641
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-29
[patent_title] => Certain chemical entities, compositions, and methods
[patent_app_type] => utility
[patent_app_number] => 15/599339
[patent_app_country] => US
[patent_app_date] => 2017-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20067
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 328
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15599339
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/599339 | Certain chemical entities, compositions, and methods | May 17, 2017 | Issued |
Array
(
[id] => 11949395
[patent_doc_number] => 20170253546
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-07
[patent_title] => 'SYNTHESIS AND BIOLOGICAL ACTIVITY OF 2-METHYLENE ANALOGS OF CALCITRIOL AND RELATED COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 15/599126
[patent_app_country] => US
[patent_app_date] => 2017-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 16254
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15599126
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/599126 | SYNTHESIS AND BIOLOGICAL ACTIVITY OF 2-METHYLENE ANALOGS OF CALCITRIOL AND RELATED COMPOUNDS | May 17, 2017 | Abandoned |
Array
(
[id] => 12092450
[patent_doc_number] => 20170349543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-07
[patent_title] => 'CATIONIC SULFONAMIDE AMINO LIPIDS AND AMPHIPHILIC ZWITTERIONIC AMINO LIPIDS'
[patent_app_type] => utility
[patent_app_number] => 15/597049
[patent_app_country] => US
[patent_app_date] => 2017-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 75
[patent_figures_cnt] => 75
[patent_no_of_words] => 48235
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15597049
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/597049 | Cationic sulfonamide amino lipids and amphiphilic zwitterionic amino lipids | May 15, 2017 | Issued |
Array
(
[id] => 16532077
[patent_doc_number] => 10874652
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-29
[patent_title] => Muscle regeneration
[patent_app_type] => utility
[patent_app_number] => 16/300283
[patent_app_country] => US
[patent_app_date] => 2017-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8123
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16300283
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/300283 | Muscle regeneration | May 14, 2017 | Issued |
Array
(
[id] => 11963550
[patent_doc_number] => 20170267703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-21
[patent_title] => 'METHOD FOR PREPARING A POLYORGANOSILOXANE AND A POLYORGANOSILOXANE'
[patent_app_type] => utility
[patent_app_number] => 15/593406
[patent_app_country] => US
[patent_app_date] => 2017-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11224
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15593406
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/593406 | METHOD FOR PREPARING A POLYORGANOSILOXANE AND A POLYORGANOSILOXANE | May 11, 2017 | Abandoned |
| 15/525880 | COMPOUND HAVING PRESERVATIVE QUALITY AND PREPARATION AND USE THEREOF | May 9, 2017 | Abandoned |
Array
(
[id] => 15038335
[patent_doc_number] => 20190330172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => 5-HYDROXYMETHYL-2-FURFURAL PRODUCTION METHOD
[patent_app_type] => utility
[patent_app_number] => 16/312566
[patent_app_country] => US
[patent_app_date] => 2017-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8687
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16312566
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/312566 | 5-hydroxymethyl-2-furfural production method | May 8, 2017 | Issued |
Array
(
[id] => 11962024
[patent_doc_number] => 20170266177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-21
[patent_title] => 'Methods for Increasing CFTR Activity'
[patent_app_type] => utility
[patent_app_number] => 15/582260
[patent_app_country] => US
[patent_app_date] => 2017-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13372
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15582260
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/582260 | Methods for increasing CFTR activity | Apr 27, 2017 | Issued |
| 15/522813 | NUCLEOSIDE KINASE INHIBITORS | Apr 27, 2017 | Abandoned |
Array
(
[id] => 12238438
[patent_doc_number] => 20180071300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-15
[patent_title] => 'METHOD OF TREATING CANCER'
[patent_app_type] => utility
[patent_app_number] => 15/496653
[patent_app_country] => US
[patent_app_date] => 2017-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 28227
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15496653
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/496653 | METHOD OF TREATING CANCER | Apr 24, 2017 | Abandoned |
Array
(
[id] => 13289091
[patent_doc_number] => 10155721
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-12-18
[patent_title] => Lignanamides and a method of treating neurodegenerative diseases by using the same
[patent_app_type] => utility
[patent_app_number] => 15/495949
[patent_app_country] => US
[patent_app_date] => 2017-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 46
[patent_no_of_words] => 5153
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15495949
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/495949 | Lignanamides and a method of treating neurodegenerative diseases by using the same | Apr 23, 2017 | Issued |
Array
(
[id] => 16474966
[patent_doc_number] => 10849886
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-01
[patent_title] => Combination therapy using azabicyclo compound for cancer
[patent_app_type] => utility
[patent_app_number] => 15/493479
[patent_app_country] => US
[patent_app_date] => 2017-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 17983
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15493479
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/493479 | Combination therapy using azabicyclo compound for cancer | Apr 20, 2017 | Issued |
Array
(
[id] => 11993879
[patent_doc_number] => 20170298033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'BISPHENOL DERIVATIVES AND THEIR USE AS ANDROGEN RECEPTOR ACTIVITY MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 15/489162
[patent_app_country] => US
[patent_app_date] => 2017-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 42640
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15489162
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/489162 | BISPHENOL DERIVATIVES AND THEIR USE AS ANDROGEN RECEPTOR ACTIVITY MODULATORS | Apr 16, 2017 | Abandoned |
Array
(
[id] => 13193865
[patent_doc_number] => 10111833
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-30
[patent_title] => Sildenafil sublingual spray formulations
[patent_app_type] => utility
[patent_app_number] => 15/488660
[patent_app_country] => US
[patent_app_date] => 2017-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10769
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15488660
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/488660 | Sildenafil sublingual spray formulations | Apr 16, 2017 | Issued |
Array
(
[id] => 11834565
[patent_doc_number] => 20170216283
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-03
[patent_title] => 'COMPOUNDS AND USES'
[patent_app_type] => utility
[patent_app_number] => 15/488760
[patent_app_country] => US
[patent_app_date] => 2017-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 38455
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15488760
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/488760 | COMPOUNDS AND USES | Apr 16, 2017 | Abandoned |